A plaintiff in Alabama has filed an Invokana complaint over the life-threatening condition she contends that the drug caused her to experience. Luana Jean Collie filed her complaint in the United States District Court, Southern District of Alabama, Southern Division on December 15, 2015. Collie’s... Read More

As patients with type 2 diabetes are increasingly prescribed drugs known as SGLT2 inhibitors to treat their illness, adverse event reports associated with the drugs are on the rise, according to a recent publication by a consumer watchdog group. The Institute for Safe Medication Practices... Read More

The use of Paxil (paroxetine) by pregnant women during their first trimester has again been linked to birth defects in their children, according to a recent review of previous scholarly studies on the subject. Although the antidepressant is considered relatively safe, it nevertheless comes with... Read More

A member of congress has sent a letter to the FDA requesting that the organization investigate whether three hospitals violated mandatory reporting policies in connection deaths related to the use of power morcellators during gynecological surgery. Michael G. Fitzpatrick, representative of the 8th district of... Read More

A mother is suing Berkeley Medical Center in West Virginia on behalf of her child for failure to hospitalize her during her pregnancy, a failure that she claims led to her infant developing Cerebral Palsy. The plaintiff claims that she was seen several times with... Read More

Adults with cerebral palsy face a significantly higher risk of several chronic conditions, including heart problems, hypertension, diabetes, and asthma, according to a recent study. The authors of a study published in the Journal of the American Medical Association (JAMA) on December 1 looked at... Read More

The FDA has refused to grant approval for AstraZeneca’s latest diabetes drug, which combines two of the company’s existing diabetes medications. The federal agency would require further data to give the drug its blessing, which would mean additional clinical trials or the completion of ongoing trials. The new... Read More

Over 50 pending lawsuits against GlaxoSmithKline concerning birth defects allegedly caused by the company’s anti-nausea medication, Zofran, have been centralized in a Massachusetts court. The United States Judicial Panel on Multidistrict Litigation issued an order on October 13 that transferred the cases to the District... Read More